Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163374 | SCV000213914 | likely benign | Hereditary cancer-predisposing syndrome | 2015-01-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000199625 | SCV000252985 | likely benign | Ataxia-telangiectasia syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000442969 | SCV000517307 | benign | not specified | 2015-06-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000163374 | SCV000537478 | likely benign | Hereditary cancer-predisposing syndrome | 2016-02-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000442969 | SCV000694366 | likely benign | not specified | 2019-08-20 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001200384 | SCV001371327 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | ATM: BP4, BP7 |
Genetic Services Laboratory, |
RCV000442969 | SCV002065787 | likely benign | not specified | 2021-11-29 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000163374 | SCV002537789 | likely benign | Hereditary cancer-predisposing syndrome | 2020-07-21 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000442969 | SCV004242550 | likely benign | not specified | 2024-02-06 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589709 | SCV005084931 | benign | Familial cancer of breast | 2024-06-18 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Prevention |
RCV004551394 | SCV004764882 | likely benign | ATM-related disorder | 2019-10-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |